In vitrogrowth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistantCandidaisolates: influence of assay conditions
- 1 January 1997
- journal article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 35 (4) , 285-287
- https://doi.org/10.1080/02681219780001291
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolatesAntimicrobial Agents and Chemotherapy, 1995
- Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosisAntimicrobial Agents and Chemotherapy, 1995
- In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373Antimicrobial Agents and Chemotherapy, 1995
- Detection of amphotericin B-resistant Candida isolates in a broth-based systemAntimicrobial Agents and Chemotherapy, 1995
- Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study GroupAntimicrobial Agents and Chemotherapy, 1995
- Antifungal susceptibility testingClinical Microbiology Reviews, 1993